According to Longboard Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$2.55. In 2022 the company made an earnings per share (EPS) of -$2.57 a decrease over its 2021 EPS that were of -$2.15.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$2.55 | -0.78% |
2022 | -$2.57 | 19.53% |
2021 | -$2.15 | 152.58% |
2020 | -$0.85 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$2.18 | -14.51% | ๐บ๐ธ USA |